Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Milhem MM, Zakharia Y, Davar D, Buchbinder EI, Medina T, Daud A, Ribas A, Chmielowski B, Niu J, Gibney GT, Margolin K, Olszanski AJ, Mehmi I, Sato T, Shaheen M, Zhao L, Kelley H, Liu H, Kumar S, Bobilev D, Krieg AM, Wooldridge JE, Kirkwood JM. Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study. Cancer. 2025 Aug 01; 131(15):e70022.
-
Moncayo AK, Ferguson JM, Dizon MP, Huhmann L, Kim DY, Do N, Brophy MT, Osborne TF, Spence AC, Fillmore NR, Swetter SM, Hartman RI. Area Deprivation Index and Melanoma Thickness in Veterans. JAMA Dermatol. 2025 Jun 01; 161(6):582-588.
-
Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, Azin M, Garza-Mayers AC, Huang JT, Nazarian RM, Horn TD, Demehri S. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Rep. 2025 May 27; 44(5):115561.
-
Meenan R, Buller DB, Berteletti J, Henry KL, Buller MK, Cutter GR, Pagoto S, Adjei I, Chirico N. Economic Evaluation of Two Scalability Strategies for Nationwide Dissemination of an Occupational Sun Safety Intervention in a Randomized Trial. J Occup Environ Med. 2025 Jul 01; 67(7):498-506.
-
Ricardo JW, Bellet JS, Jellinek N, Lee D, Miller CJ, Piraccini BM, Richert B, Rubin AI, Lipner SR. Evaluation and diagnosis of longitudinal melanonychia: A clinical review by a nail expert group. J Am Acad Dermatol. 2025 Jul; 93(1):176-187.
-
Flynn EN, Dadras SS, Petty A, Olugbade ID, Imahiyerobo-Ip J. Blastic plasmacytoid dendritic cell neoplasm. Dermatol Online J. 2025 Feb 15; 31(1).
-
Cabrera-Perez JS, Carey VJ, Odejide OO, Singh S, Kupper TS, Pillai SS, Weiss ST, Akenroye A. Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy. J Allergy Clin Immunol. 2025 May; 155(5):1584-1594.
-
Karpinski P, Mendez-Pena JE, Wu CL, Akalin A, Cornejo KM, Hung YP, Hoang MP. POU4F3 Is a Sensitive and Specific Marker of Merkel Cell Carcinoma. Mod Pathol. 2025 Jan; 38(1):100627.
-
Kumar EA, Morris LM, Michalski-McNeely BM. Tranexamic Acid in Mohs Micrographic Surgery: A Systematic Review. Dermatol Surg. 2025 01 01; 51(1):17-19.
-
Challapalli A, Stewart G, Shaw H, Davies PJ, Lopez-Baez JC, Ottley EC, Kelly S. Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab). Front Immunol. 2024; 15:1408667.